Comparison of HCV viral load and its genotype distributions in HCV mono- and HIV/HCV co-infected illicit drug users
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1743-422X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Comparison of HCV viral load and its genotype distributions in HCV mono- and HIV/HCV co-infected illicit drug users ; volume:14 ; number:1 ; day:11 ; month:7 ; year:2017 ; pages:1-6 ; date:12.2017
Virology journal ; 14, Heft 1 (11.7.2017), 1-6, 12.2017
- Klassifikation
-
Medizin, Gesundheit
- Urheber
-
Jamalidoust, Marzieh
- Beteiligte Personen und Organisationen
-
Namayandeh, Mandana
Moghadami, Mohsen
Ziyaeyan, Mazyar
SpringerLink (Online service)
- DOI
-
10.1186/s12985-017-0797-2
- URN
-
urn:nbn:de:1111-2017080912139
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:31 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Jamalidoust, Marzieh
- Namayandeh, Mandana
- Moghadami, Mohsen
- Ziyaeyan, Mazyar
- SpringerLink (Online service)
Ähnliche Objekte (12)
HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes
German cohort of HCV mono-infected and HCV/HIV co-infected patients reveals relative under-treatment of co-infected patients
MicroRNA signature from extracellular vesicles of HCV/HIV co-infected individuals differs from HCV mono-infected
Effectiveness of HCV core antigen and RNA quantification in HCV-infected and HCV/HIV-1-coinfected patients
Insights on the Russian HCV care cascade: minimal HCV treatment for HIV/HCV co-infected PWID in St. Petersburg
Impact of HCV viremia on HBV biomarkers in patients coinfected with HBV and HCV
HCV
HCV genotype 1a shows a better virological response to antiviral therapy than HCV genotype 1b
Inhibition of HCV 3a genotype entry through Host CD81 and HCV E2 antibodies
Effectiveness of ombitasvir/paritaprevir/ritonavir, dasabuvir for HCV in HIV/HCV coinfected subjects: a comprehensive analysis
Efficacy and tolerability of DAAs in HCV-monoinfected and HCV/HIV-coinfected patients with psychiatric disorders
Contemporary HCV pangenotypic DAA treatment protocols are exclusionary to real world HIV-HCV co-infected patients
HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes
German cohort of HCV mono-infected and HCV/HIV co-infected patients reveals relative under-treatment of co-infected patients
MicroRNA signature from extracellular vesicles of HCV/HIV co-infected individuals differs from HCV mono-infected
Effectiveness of HCV core antigen and RNA quantification in HCV-infected and HCV/HIV-1-coinfected patients
Insights on the Russian HCV care cascade: minimal HCV treatment for HIV/HCV co-infected PWID in St. Petersburg
Impact of HCV viremia on HBV biomarkers in patients coinfected with HBV and HCV
HCV
HCV genotype 1a shows a better virological response to antiviral therapy than HCV genotype 1b
Inhibition of HCV 3a genotype entry through Host CD81 and HCV E2 antibodies
Effectiveness of ombitasvir/paritaprevir/ritonavir, dasabuvir for HCV in HIV/HCV coinfected subjects: a comprehensive analysis
Efficacy and tolerability of DAAs in HCV-monoinfected and HCV/HIV-coinfected patients with psychiatric disorders
Contemporary HCV pangenotypic DAA treatment protocols are exclusionary to real world HIV-HCV co-infected patients
HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes
German cohort of HCV mono-infected and HCV/HIV co-infected patients reveals relative under-treatment of co-infected patients
MicroRNA signature from extracellular vesicles of HCV/HIV co-infected individuals differs from HCV mono-infected
Effectiveness of HCV core antigen and RNA quantification in HCV-infected and HCV/HIV-1-coinfected patients
Insights on the Russian HCV care cascade: minimal HCV treatment for HIV/HCV co-infected PWID in St. Petersburg
Impact of HCV viremia on HBV biomarkers in patients coinfected with HBV and HCV
HCV
HCV genotype 1a shows a better virological response to antiviral therapy than HCV genotype 1b
Inhibition of HCV 3a genotype entry through Host CD81 and HCV E2 antibodies
Effectiveness of ombitasvir/paritaprevir/ritonavir, dasabuvir for HCV in HIV/HCV coinfected subjects: a comprehensive analysis
Efficacy and tolerability of DAAs in HCV-monoinfected and HCV/HIV-coinfected patients with psychiatric disorders